Author: healthadmin

of environmental protection agency It is reconsidering whether facilities that chemically recycle plastics should be held to the same strict air pollution standards as incineration facilities.The potential change has alarmed environmentalists, who say it will cause further damage. dangerous pollution Spitting it out into the community with little or no checks at the federal level. The plastics industry disputes this, saying it can eliminate disruption while curbing emissions.the world is exciting Millions of tons of plastic pollution It is released into the environment every year. meanwhile dozens of countries And while many environmental groups are calling for caps on production…

DES MOINES, Iowa — Aaron Lehman has many concerns about the fate of Iowa farmers. There is more than one climate change lawsuit. But state lawmakers disagree with Iowa Farmers Union President Lehman. Instead, they pushed through legislation to protect agricultural businesses from lawsuits over the climate impacts of greenhouse gas emissions. The bill currently awaits Governor Kim Reynolds’ signature. In 2018, residents in northeast Iowa announced plans to sue the Department of Natural Resources for failing to regulate air emissions from hog facilities, but did not file a lawsuit. Even then, the challenge would have been directed at national…

Imagine a swarm of robots rushing to complete an urgent task, like cleaning up an oil spill or assembling a complex machine. Initially, adding robots will speed up the process. However, after a certain point, the space becomes crowded and robots begin to interfere with each other, slowing down overall progress. This raises a simple but important question. How many robots can we deploy in a limited area before efficiency starts to decline? Researchers at Harvard University believe they have found a clear answer. Simple ideas to increase efficiency New research from the lab of L. Mahadevan, Laura Englund de…

A proposal to require ambient air monitoring systems at high-emission industrial facilities in Louisiana was in limbo Tuesday and is highly unlikely to move forward. Air monitoring equipment is needed Senate Bill 356The plan, sponsored by Sen. Lois Duplessis (D-New Orleans), would have provided early warning to nearby residents to seek safety if toxic pollutants were released. However, members of the Senate Environmental Quality Committee took no action after Duplessis introduced the bill. Sen. Ed Price (D-Gonzalez), the only Democrat on the eight-member committee, was not present when the bill was considered, but his presence would not have made much…

ORGAPRED, a French-based center of excellence specializing in patient-derived tumor organoid (PDTO) research, has selected Hamamatsu Photonics France’s high-throughput 3D imaging system CYTOQUBE to support personalized oncology drug screening and therapeutic discovery. This system enables rapid multicolor analysis of PDTO, enhancing ORGAPRED’s ability to assess treatment efficacy in these models. Hamamatsu x ORGAPRED team. From left: DESMARTIN Guillaume, EMICA Bruno, KOSSAYER Ghenwa, LECOUFLET Lucie, FLORENT Romane, D’ANGELO Jean Marc, Divoux Jordane, WEISWALD Louis-Bastien, POULAIN LAURENT, LE GOFF Jérémie. Image credit: © Hamamatsu Photonics Supporting personalized cancer treatment research and drug discovery ORGAPRED is an innovative center of excellence dedicated to…

A new large-scale study led by researchers at the University of Nottingham has found that a drug commonly used to treat gout may reduce the risk of heart attack and stroke in gout patients. The survey results are JAMA Internal Medicinesuggest that lowering blood uric acid levels to recommended target levels not only reduces gout symptoms but may also help prevent serious cardiovascular events. The research was led by Professor Abhishek from the University of Nottingham’s School of Medicine, in collaboration with collaborators from Keele University and the London School of Hygiene and Tropical Medicine in the UK, the University…

Bio-Rad Laboratories, a global leader in life science research and clinical diagnostic products, today expanded its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of eight antibodies specific for romozumab (Evenity), burosumab (Crysvita), ixekizumab (Taltz), elotuzumab (Empliciti), isacuximab (Sarclisa), and nilsevimab. (Beyfortus), and tremelimumab (Imjudo), and released a recombinant monoclonal antibiotic therapy antibody specific for dulaglutide (Trulicity). The company also launched the first series of anti-Fc mutant antibodies targeting drugs containing YTE mutations. Bio-Rad anti-idiotype antibodies.Image credit: Bio-Rad Laboratories, Inc. Bio-Rad’s series of highly specific, high-affinity, non-animal-derived antibodies are suitable for use in preclinical and clinical pharmacokinetic (PK) and…

SPT Labtech, a world leader in the design and development of laboratory automation and liquid handling solutions, and the European Molecular Biology Laboratory’s Genomics Core Facility (EMBL GeneCore) today announced a partnership to power fully walk-away automated genomics workflows. As part of the collaboration, SPT Labtech’s firefly®+ all-in-one liquid handling platform was installed at EMBL GeneCore, an internationally recognized, state-of-the-art genomics service center. Through the installation of firefly+, EMBL GeneCore will expand its ability to develop new protocols, further validate and optimize existing workflows for challenging applications such as low input and metagenomics samples, and support the broader genomics community.…

ProImmune, Ltd., a global leader in immunological reagents and services, today announced a partnership with the University of Texas Medical Branch (UTMB) Galveston National Laboratory (GNL), a highly contained infectious disease research facility, to develop innovative tools to study high-severity emerging and endemic infectious diseases. Under the agreement, ProImmune’s Ankyrons will be evaluated as a molecular tool that enables precise detection, localization, and functional interrogation of viral proteins across complex experimental systems compatible with high-containment studies. The collaboration combines ProImmune’s Ankyron® target binding reagent technology with GNL’s expertise in the immunopathology of emerging viruses. The research will be conducted in…

VALANX Biotech (VALANX), a biotechnology company developing new technologies for site-specific protein binding in drug discovery, today announced the formation of a Scientific Advisory Board (SAB), appointing John Lambert as chair, with Morris Rosenberg and Peter de Waele joining. The newly formed SAB will provide independent scientific and strategic guidance and bridge the gap between research and clinical application to advance the company’s antibody-drug conjugate (ADC) program, including VLX-ADC-001, a LIV-1-targeted ADC targeting metastatic triple-negative breast cancer, with lead candidate selection expected in June 2026. SAB’s CMC expertise will also support the implementation of the company’s GoldenSite™ technology into GMP…